Literature DB >> 1911207

Compliance with follow-up of patients treated for non-seminomatous testicular cancer.

B J Young1, B D Bultz, J A Russell, M S Trew.   

Abstract

Many patients with Stage 1 non-seminomas are now treated by orchidectomy and close follow-up along. Chart review indicated that a group of such patients, compared with patients treated with chemotherapy, tended to be less compliant with follow-up. A questionnaire given to a second sample of patients confirmed that surgical patients underestimated the dangers of the disease and chances of relapse, and doubted the value of follow-up.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1911207      PMCID： PMC1977654          DOI： 10.1038/bjc.1991.359

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  4 in total

1.  Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.

Authors:  P C Sogani; W F Whitmore; H W Herr; G J Bosl; R B Golbey; R C Watson; J J DeCosse
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

2.  The structure and reliability of health belief indices.

Authors:  A M Jette; K M Cummings; B M Brock; M C Phelps; J Naessens
Journal:  Health Serv Res       Date:  1981       Impact factor: 3.402

3.  Development of scales to measure beliefs of diabetic patients.

Authors:  G W Given; B A Given; R S Gallin; J W Condon
Journal:  Res Nurs Health       Date:  1983-09       Impact factor: 2.228

4.  Women's health beliefs about breast cancer and breast self-examination.

Authors:  M J Stillman
Journal:  Nurs Res       Date:  1977 Mar-Apr       Impact factor: 2.381
  4 in total
  5 in total

1.  Cost- and risk-benefit considerations in the management of clinical stage I nonseminomatous testicular tumors.

Authors:  J Baniel; B J Roth; R S Foster; J P Donohue
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

2.  Prospective study of factors predicting adherence to medical advice in men with testicular cancer.

Authors:  Clare Moynihan; Andy R Norman; Yolanda Barbachano; Louise Burchell; Robert Huddart; David P Dearnaley; Alan Horwich
Journal:  J Clin Oncol       Date:  2009-03-23       Impact factor: 44.544

3.  Refusal in testicular cancer patients: implications for surveillance.

Authors:  J W Moul
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

4.  How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?

Authors:  S D Fosså; A B Jacobsen; N Aass; A Heilo; A E Stenwig; O Kummen; N B Johannessen; G Waaler; P Ogreid; L Borge
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

Review 5.  A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists.

Authors:  G C Howard; K Clarke; M H Elia; A W Hutcheon; S B Kaye; P M Windsor
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.